Yi-Ping Lin

Yi-Ping Lin, Ph.D. has extensive experience in the field of quality regulatory and clinical affairs. Their work history includes senior leadership roles in various companies within the healthcare industry. They began their career as a Principal Scientist at Roche in 1993 and later joined Johnson & Johnson as a Director in 1998. They held the position of Director at Roche Molecular Systems from 2003 to 2009. In 2009, they joined Abbott Laboratories as a Director of Quality Regulatory and Compliance. Following this, they served as Vice President of Quality Assurance and Regulatory Affairs at Beckman Coulter from 2014 to 2017. From 2017 to 2023, they worked as a Senior Vice President in Quality Regulatory and Clinical Affairs at Cepheid. In 2023, they became a Senior Vice President at PerkinElmer, Inc. and subsequently joined Revvity in the same position later that year.

Yi-Ping Lin, Ph.D., completed their Biochemistry Ph.D. from Rutgers University between 1986 and 1991.